NK cells are among the early responders, and by lysing cancer cells, they expose tumor antigens to the care of DCs, which present them to T-cells in tumor-draining lymph nodes to induce polarization of CD4 T-cells into Th1 helper cells and the conversion of CD8 T-cells into cytotoxic T-cells (CTL). The gene discussed is CD4; the disease is cancer.